Cytokinetics
CYTK | NASDAQ
$62.73
-$0.26 (-0.41%)
Nov 2, 2026, 3:19 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -198.76M | -206.03M | -183.03M | -306.18M | -134.37M | -161.38M | -150.02M | -160.55M | -143.32M | -135.64M | -136.9M | -129.42M | -128.64M | -131.29M | -137.38M | -142.31M | -19.82M | -89.45M | -30.57M | -76.09M | -61.55M | -47.1M |
Depreciation & Amortization | 3.63M | 3.38M | 2.86M | 2.68M | 2.29M | 2.3M | 2.38M | 2.41M | 2.41M | 2.33M | 6.34M | 1.85M | 1.86M | 2.78M | 1.66M | 2.09M | 1.41M | 1.34M | 734K | 462K | 543K | 537K |
Stock-Based Compensation | 35.71M | 30.39M | n/a | 30.7M | 27.54M | 23.55M | 26.25M | 25.36M | 24.62M | 21.61M | 19.49M | 18.72M | 18.67M | n/a | 13.5M | n/a | 12.2M | 8.99M | 6.71M | 7.77M | 7.09M | 5.26M |
Other Working Capital | -5.41M | -9.11M | 14.42M | 9.33M | -45.66M | -15.27M | 52.22M | 8.41M | 10.74M | -15.86M | 35.95M | 1.76M | -19.8M | -10.21M | 1.65M | 8.65M | -89M | -7.19M | 13.28M | 18.94M | 13.21M | 9.37M |
Other Non-Cash Items | 24.82M | 27.02M | 39.36M | 142.77M | 27.43M | 9.11M | 14.1M | 21.39M | 7.21M | 7.89M | 15.39M | 11.17M | 10.41M | 25.39M | 7.19M | 46.86M | 9.51M | 11.82M | 12.42M | 8.52M | 7.73M | 6.56M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -23.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -25.24M | -219K | -1.85M | 22.53M | -51.11M | -5.2M | 41.71M | 9.88M | 9.77M | -25.7M | 44.88M | 1.48M | -24.1M | -19.17M | 16.84M | 11.73M | -93.77M | 40.49M | -34.04M | 20.57M | 16.69M | 5.23M |
Operating Cash Flow | -159.84M | -145.46M | -142.65M | -107.51M | -128.24M | -131.62M | -65.57M | -101.5M | -99.31M | -129.51M | -74.04M | -96.21M | -121.81M | -122.29M | -98.19M | -81.63M | -90.48M | -26.81M | -44.74M | -38.77M | -29.5M | -29.52M |
Capital Expenditures | -4.33M | -5.93M | -5.64M | -9.35M | -4.15M | -5.66M | -1.29M | -2.46M | -1.92M | 1.75M | -77K | -220K | -717K | -402K | -3.21M | -6.33M | -857K | -942K | -17.75M | -15.7M | -8.79M | -6.63M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 81.33M | -73.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -727.27M | -106.52M | -350.65M | -335.45M | -217.97M | -164.11M | -121.13M | -214.4M | -815.24M | -142.66M | -226.12M | -117.73M | -201.59M | -89.78M | -125.18M | -467.18M | -69.91M | -193.13M | -31.59M | -321.59M | -105.66M | -66.2M |
Sales Maturities Of Investments | 224.6M | 257.94M | 280.1M | 273.83M | 279.99M | 275.73M | 233.28M | 170.05M | 165.6M | 175.3M | 144.78M | 190.98M | 284.44M | 255.68M | 157.63M | 181.14M | 136.04M | 129.79M | 96.68M | 128.57M | 133.33M | 67.55M |
Other Investing Acitivies | n/a | n/a | 5M | n/a | -5M | n/a | n/a | 1.75M | n/a | -1.75M | -81.33M | 73.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -507M | 145.49M | -71.19M | -70.98M | 52.88M | 105.96M | 110.86M | -45.05M | -651.55M | 32.64M | -81.41M | 73.04M | 82.13M | 165.5M | 29.25M | -292.37M | 65.27M | -64.28M | 47.34M | -208.72M | 18.88M | -5.28M |
Debt Repayment | -3.59M | -2.74M | 172.28M | 324.25M | -2.7M | -2.88M | -2.91M | -2.89M | -2.88M | -932K | -222K | -217K | -212K | -207K | -149.69M | 530M | -267K | -47.8M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | 21.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.84M | 3.68M | -9.6M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.7M | -841K | -76.22M | -720K | 74.49M | -13K | -1.18M | n/a | 210.69M | 11.08M | 6.1M | 53.12M | n/a | -10.52M | 162.03M | -145.24M | n/a | 151.25M | 4.36M | 842K | 6.35M | -7.19M |
Financial Cash Flow | 792.86M | 7.77M | 110.71M | 330.47M | 78.53M | 4.75M | 2.38M | 3.43M | 821.01M | 103.79M | 168.8M | 54.22M | 5.48M | -7.18M | 29.89M | 386.61M | 3.42M | 93.85M | 19.51M | 300.9M | 3.18M | -3.6M |
Net Cash Flow | 125.42M | 7.32M | -102.95M | 152.03M | 2.5M | -21.18M | 47.97M | -143.25M | 70.17M | 6.95M | 13.33M | 31.05M | -34.2M | 37.63M | -40.66M | 12.61M | -21.79M | 2.76M | 22.1M | 53.41M | -7.44M | -38.39M |
Free Cash Flow | -164.17M | -151.39M | -148.29M | -116.86M | -132.38M | -137.28M | -66.86M | -103.96M | -101.23M | -127.75M | -74.11M | -96.43M | -122.52M | -122.69M | -101.4M | -87.96M | -91.33M | -27.75M | -62.49M | -54.47M | -38.29M | -36.15M |
Adj. Free Cash Flow | -199.89M | -181.78M | -148.29M | -147.56M | -159.92M | -160.83M | -93.11M | -129.31M | -125.85M | -149.37M | -93.6M | -115.14M | -141.19M | -122.69M | -114.89M | -87.96M | -103.53M | -36.74M | -69.2M | -62.24M | -45.38M | -41.41M |
Maintenance CapEx | -3.63M | -3.38M | -3.85M | -6.17M | n/a | -4.05M | n/a | -2.28M | -1.92M | 1.75M | -77K | -220K | -717K | n/a | -3.21M | -6.33M | n/a | -942K | n/a | -15.7M | -8.79M | -5.09M |
Growth CapEx | -703K | -2.55M | -1.79M | -3.19M | -4.15M | -1.61M | -1.29M | -175.78K | n/a | n/a | n/a | n/a | n/a | -402K | n/a | n/a | -857K | n/a | -17.75M | n/a | n/a | -1.54M |
Owner Earnings | -163.47M | -148.84M | -146.5M | -113.67M | -128.24M | -135.67M | -65.57M | -103.78M | -101.23M | -127.75M | -74.11M | -96.43M | -122.52M | -122.29M | -101.4M | -87.96M | -90.48M | -27.75M | -44.74M | -54.47M | -38.29M | -34.61M |
Add to Watchlist
Select watchlists to add or remove CYTK